204 related articles for article (PubMed ID: 22521289)
1. Erythropoietin alleviates post-ischemic injury of rat hearts by attenuating nitrosative stress.
Lu MJ; Chen YS; Huang HS; Ma MC
Life Sci; 2012 May; 90(19-20):776-84. PubMed ID: 22521289
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin protects post-ischemic hearts by preventing extracellular matrix degradation: role of Jak2-ERK pathway.
Chan CY; Chen YS; Lee HH; Huang HS; Lai YL; Chen CF; Ma MC
Life Sci; 2007 Aug; 81(9):717-23. PubMed ID: 17707437
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin after focal cerebral ischemia activates the Janus kinase-signal transducer and activator of transcription signaling pathway and improves brain injury in postnatal day 7 rats.
Sola A; Rogido M; Lee BH; Genetta T; Wen TC
Pediatr Res; 2005 Apr; 57(4):481-7. PubMed ID: 15718373
[TBL] [Abstract][Full Text] [Related]
4. The effects of curcumin post-treatment against myocardial ischemia and reperfusion by activation of the JAK2/STAT3 signaling pathway.
Duan W; Yang Y; Yan J; Yu S; Liu J; Zhou J; Zhang J; Jin Z; Yi D
Basic Res Cardiol; 2012 May; 107(3):263. PubMed ID: 22466958
[TBL] [Abstract][Full Text] [Related]
5. Direct cardiac actions of erythropoietin (EPO): effects on cardiac contractility, BNP secretion and ischaemia/reperfusion injury.
Piuhola J; Kerkelä R; Keenan JI; Hampton MB; Richards AM; Pemberton CJ
Clin Sci (Lond); 2008 Feb; 114(4):293-304. PubMed ID: 17919123
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte colony stimulating factor directly inhibits myocardial ischemia-reperfusion injury through Akt-endothelial NO synthase pathway.
Ueda K; Takano H; Hasegawa H; Niitsuma Y; Qin Y; Ohtsuka M; Komuro I
Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):e108-13. PubMed ID: 16574892
[TBL] [Abstract][Full Text] [Related]
7. Effects of supplemental erythropoietin on its receptor expression and signal transduction pathways in rat model of retinal detachment.
Xie Z; Chen F; Wu X; Zhuang C; Zhu J; Wang J; Ji H; Wang Y; Hua X
Curr Eye Res; 2012 Feb; 37(2):138-44. PubMed ID: 22251399
[TBL] [Abstract][Full Text] [Related]
8. β Common receptor integrates the erythropoietin signaling in activation of endothelial nitric oxide synthase.
Su KH; Shyue SK; Kou YR; Ching LC; Chiang AN; Yu YB; Chen CY; Pan CC; Lee TS
J Cell Physiol; 2011 Dec; 226(12):3330-9. PubMed ID: 21321940
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo.
Bullard AJ; Govewalla P; Yellon DM
Basic Res Cardiol; 2005 Sep; 100(5):397-403. PubMed ID: 15944807
[TBL] [Abstract][Full Text] [Related]
10. Impairment of cardioprotective PI3K-Akt signaling by post-infarct ventricular remodeling is compensated by an ERK-mediated pathway.
Miki T; Miura T; Tanno M; Nishihara M; Naitoh K; Sato T; Takahashi A; Shimamoto K
Basic Res Cardiol; 2007 Mar; 102(2):163-70. PubMed ID: 16944359
[TBL] [Abstract][Full Text] [Related]
11. Selective modulation of endogenous nitric oxide formation in ischemia/reperfusion injury in isolated rat hearts--effects on regional myocardial flow and enzyme release.
Han H; Kaiser R; Hu K; Laser M; Ertl G; Bauersachs J
Basic Res Cardiol; 2003 May; 98(3):165-74. PubMed ID: 12883834
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways.
Rafiee P; Shi Y; Su J; Pritchard KA; Tweddell JS; Baker JE
Basic Res Cardiol; 2005 May; 100(3):187-97. PubMed ID: 15611843
[TBL] [Abstract][Full Text] [Related]
13. Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure.
Li Y; Takemura G; Okada H; Miyata S; Maruyama R; Li L; Higuchi M; Minatoguchi S; Fujiwara T; Fujiwara H
Cardiovasc Res; 2006 Sep; 71(4):684-94. PubMed ID: 16828072
[TBL] [Abstract][Full Text] [Related]
14. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
[TBL] [Abstract][Full Text] [Related]
15. Schwann cells express erythropoietin receptor and represent a major target for Epo in peripheral nerve injury.
Li X; Gonias SL; Campana WM
Glia; 2005 Sep; 51(4):254-65. PubMed ID: 15812815
[TBL] [Abstract][Full Text] [Related]
16. Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway.
Zhu M; Feng J; Lucchinetti E; Fischer G; Xu L; Pedrazzini T; Schaub MC; Zaugg M
Cardiovasc Res; 2006 Oct; 72(1):152-62. PubMed ID: 16901477
[TBL] [Abstract][Full Text] [Related]
17. Role of STAT3 in ischemic preconditioning.
Hattori R; Maulik N; Otani H; Zhu L; Cordis G; Engelman RM; Siddiqui MA; Das DK
J Mol Cell Cardiol; 2001 Nov; 33(11):1929-36. PubMed ID: 11708838
[TBL] [Abstract][Full Text] [Related]
18. Increased resistance to myocardial ischemia in the Brown Norway vs. Dahl S rat: role of nitric oxide synthase and Hsp90.
Shi Y; Hutchins W; Ogawa H; Chang CC; Pritchard KA; Zhang C; Khampang P; Lazar J; Jacob HJ; Rafiee P; Baker JE
J Mol Cell Cardiol; 2005 Apr; 38(4):625-35. PubMed ID: 15808839
[TBL] [Abstract][Full Text] [Related]
19. Absence of inducible nitric oxide synthase modulates early reperfusion-induced NF-kappaB and AP-1 activation and enhances myocardial damage.
Zingarelli B; Hake PW; Yang Z; O'Connor M; Denenberg A; Wong HR
FASEB J; 2002 Mar; 16(3):327-42. PubMed ID: 11874982
[TBL] [Abstract][Full Text] [Related]
20. Aldose reductase pathway mediates JAK-STAT signaling: a novel axis in myocardial ischemic injury.
Hwang YC; Shaw S; Kaneko M; Redd H; Marrero MB; Ramasamy R
FASEB J; 2005 May; 19(7):795-7. PubMed ID: 15746188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
